Teabe meditsiiniseadmete vajadusega seotud pakkumismenetluste kohta leiate COVID-19 teemaliselt veebilehelt.

Euroopa tuleviku konverents annab võimaluse jagada oma ideid ja kujundada Euroopa tulevikku. Tehke oma hääl kuuldavaks!

Tarned - 246846-2016

19/07/2016    S137

Belgium-Brussels: Purchase, storage and delivery of live attenuated vaccine against lumpy skin disease

2016/S 137-246846

Contract notice


Legal Basis:
Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses
Official name: European Commission, Directorate-General for Health and Food Safety
Town: Brussels
NUTS code: BE100 Arr. de Bruxelles-Capitale / Arr. van Brussel-Hoofdstad
Postal code: 1049
Country: Belgium
Contact person: Marc Vallons
E-mail: sante-procurement@ec.europa.eu
Telephone: +32 22954439
Internet address(es):
Main address: http://ec.europa.eu/dgs/health_food-safety/index_en.htm
The procurement documents are available for unrestricted and full direct access, free of charge, at: https://etendering.ted.europa.eu/cft/cft-display.html?cftId=1710
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be submitted to the abovementioned address
I.4)Type of the contracting authority
European institution/agency or international organisation
I.5)Main activity
General public services

Section II: Object

II.1)Scope of the procurement

Purchase, storage and delivery of live attenuated vaccine against lumpy skin disease.

Reference number: SANTE/2016/G2/030.
II.1.2)Main CPV code
33651690 Vaccines for veterinary medicine
II.1.3)Type of contract
II.1.4)Short description:

The Commission intends to maintain a stock of live attenuated LSD vaccine in storage in order to make it rapidly available in case it is needed. In addition, this stock of live attenuated vaccine should be replaced quickly, when depleted, in order to maintain the Union's capability to respond to an emergency.

II.1.5)Estimated total value
Value excluding VAT: 600 000.00 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2.3)Place of performance
NUTS code: BE10 Région de Bruxelles-Capitale / Brussels Hoofdstedelijk Gewest
II.2.4)Description of the procurement:

See Internet address provided in Section I.3.

II.2.5)Award criteria
Criteria below
II.2.6)Estimated value
Value excluding VAT: 600 000.00 EUR
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 48
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information

The duration of the contract is 48 months after the signature of the contract by the last contracting party, extended with the remaining shelf life of the vaccines in stock at the end of this initial contract duration.

Section III: Legal, economic, financial and technical information

III.1)Conditions for participation
III.1.1)Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers
List and brief description of conditions:

See Internet address provided in Section I.3.

III.1.2)Economic and financial standing
Selection criteria as stated in the procurement documents
III.1.3)Technical and professional ability
Selection criteria as stated in the procurement documents

Section IV: Procedure

IV.1.1)Type of procedure
Open procedure
Accelerated procedure

The recent increase of LSD outbreaks in Greece and Bulgaria and the fact that LSD without proper control tends to spread unexpectedly over long distances mainly due to movements of animals, and over mid-distances exclusively due to vectors activity, makes that other Member States such as Romania are at direct risk too. Additional support in the form of LSD vaccines is also needed for the former Yugoslav Republic of Macedonia to prevent further spread to other EU Member States.

The urgency of the situation renders the normal time limits for open procedures impracticable because vaccines must be administered before the end of the summer.

IV.1.3)Information about a framework agreement or a dynamic purchasing system
IV.1.8)Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: yes
IV.2)Administrative information
IV.2.2)Time limit for receipt of tenders or requests to participate
Date: 02/08/2016
Local time: 17:00
IV.2.3)Estimated date of dispatch of invitations to tender or to participate to selected candidates
IV.2.4)Languages in which tenders or requests to participate may be submitted:
Bulgarian, Czech, Danish, German, Greek, English, Spanish, Estonian, Finnish, French, Irish, Croatian, Hungarian, Italian, Lithuanian, Latvian, Maltese, Dutch, Polish, Portuguese, Romanian, Slovak, Slovenian, Swedish
IV.2.6)Minimum time frame during which the tenderer must maintain the tender
Duration in months: 6 (from the date stated for receipt of tender)
IV.2.7)Conditions for opening of tenders
Date: 08/08/2016
Local time: 9:30

rue Breydel 4 — B232 6/17A, 1040 Brussels, BELGIUM.

Information about authorised persons and opening procedure:

See Internet address provided in Section I.3.

Section VI: Complementary information

VI.1)Information about recurrence
This is a recurrent procurement: no
VI.3)Additional information:

See Internet address provided in Section I.3.

VI.4)Procedures for review
VI.4.1)Review body
Official name: General Court
Postal address: rue du Fort Niedergrünewald
Town: Luxembourg
Postal code: 2925
Country: Luxembourg
E-mail: generalcourt.registry@curia.europa.eu
Telephone: +352 4303-1
Fax: +352 4303-2100
Internet address: http://curia.europa.eu/
VI.4.3)Review procedure
Precise information on deadline(s) for review procedures:

See Internet address provided in Section I.3.

VI.5)Date of dispatch of this notice: